REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE
SILVER SPRING, Maryland
Total Received
$318.6M
Total Awards
123
State
Maryland
Last Updated
Mar 20, 2026
Yearly Funding Trend
$240.8M24
$62.8M25
$14.9M26
Top 50 Awards to REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_UM1AI164559_075 HOPE - HIV OBSTRUCTION BY PROGRAMMED EPIGENETICS - PROJECT SUMMARY/ABSTACT AFTER 40 YEARS, A CURE FOR PEOPLE LIVING WITH HIV (PLWH) REMAINS BOTH ELUSIVE AND ONE OF NIAID/NIH’S HIG… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $27,293,591 |
ASST_NON_P01AG073082_075 DECODING THE MULTIFACTORIAL ETIOLOGY OF NEURAL NETWORK DYSFUNCTION IN ALZHEIMER'S DISEASE - OVERALL – SUMMARY ALZHEIMER’S DISEASE (AD) IS A MAJOR UNRESOLVED PUBLIC HEALTH PROBLEM.… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $23,431,388 |
ASST_NON_P01HL146366_075 COMBINATORIAL REGULATION OF GENE NETWORKS DURING CARDIAC DEVELOPMENT AND DISEASE - PROJECT SUMMARY/ABSTRACT OVERALL COMPONENT CARDIOVASCULAR DISEASE IS THE MOST COMMON CAUSE OF MO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2025 | $13,661,675 |
ASST_NON_R35NS097976_075 NEUROVASCULAR INTERACTIONS: MECHANISMS, IMAGING, THERAPEUTIC POTENTIAL - PROJECT SUMMARY/ABSTRACT THE NEUROVASCULAR INTERFACE FUNDAMENTALLY CHANGES DURING CNS DISEASES DUE TO INCR… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CA-90 | 2024 | $11,091,898 |
ASST_NON_R01HL057181_075 CARDIOGENESIS: MOLECULAR MECHANISMS - PROJECT SUMMARY CONGENITAL HEART DISEASE IS THE RESULT OF ABNORMAL DEVELOPMENT OF DISCRETE SUB-TYPES OF CARDIOGENIC CELLS DURING EARLY EMBRYO… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $10,428,454 |
ASST_NON_P01AI131374_075 EXPLOITING THE HOST-HIV INTERFACE TO IDENTIFY BIOMARKERS PREDICTING TIME TO VIRAL REBOUND AFTER TREATMENT INTERRUPTION - PROJECT SUMMARY/ABSTRACT THE DEVELOPMENT AND TESTING OF PO… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $8,474,394 |
ASST_NON_R01HL114948_075 EARLY CARDIAC PROGENITORS - SUMMARY THE MAMMALIAN HEART FORMS EARLY IN EMBRYOGENESIS, AND DEFECTS IN ITS FORMATION ARE AT THE ROOT OF CONGENITAL HEART DEFECTS (CHDS), AFFECTING 1–… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $6,783,898 |
ASST_NON_R37AI109593_075 MODULATING STOCHASTIC GENE EXPRESSION FOR CELL-FATE CONTROL AND THERAPEUTICS - PROJECT SUMMARY STOCHASTIC FLUCTUATIONS IN GENE EXPRESSION ARE UNAVOIDABLE AT THE SINGLE-CELL LEVEL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | ROCKVILLE, MD-08 | 2024 | $6,380,149 |
ASST_NON_DP1DA051144_075 A GENE DRIVE THERAPY FOR HIV: SINGLE-ADMINISTRATION INTERVENTION FOR HIGH-RISK GROUPS - ! PROJECT SUMMARY EPIDEMIOLOGISTS HAVE LONG RECOGNIZED THE IMMENSE POTENTIAL OF TARGETING… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2024 | $5,693,662 |
ASST_NON_RF1NS139975_075 VASCULAR-IMMUNE MECHANISMS OF CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S PATHOLOGY - COGNITIVE DECLINE IN THE AGING BRAIN IS DRIVEN BY OVERLAPPING NEURODEGENERATIVE AND CEREBROVA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $5,423,836 |
ASST_NON_RF1AG063519_075 NEURAL NETWORK AND IMMUNE CELL DYSFUNCTIONS IN ALZHEIMER'S DISEASE PATHOGENESIS - RESEARCH ON ALZHEIMER’S DISEASE (AD) HAS STRONGLY FOCUSED ON PATHOLOGICAL ALTERATIONS DETECTABLE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $5,008,839 |
ASST_NON_R37AI083139_075 ROLE OF FACTOR ACETYLATION IN THE REGULATION OF HIV TRANSCRIPTION - FULLY EXPLOITING THE PROMISE OF FACTOR ACETYLATION AS A RELEVANT DRUG TARGET IN HIV INFECTION HAS THE POTENTIAL… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $4,796,303 |
ASST_NON_R01DA059551_075 SORTING AND SEQUENCING LATENT RESERVOIRS IN HIV+ OPIOID USERS - ABSTRACT OPIOID USERS ARE PRIME BENEFICIARIES OF CURE STRATEGIES FOR HIV DUE TO THEIR MEDICAL AND SOCIAL VULNERABIL… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2024 | $4,748,827 |
ASST_NON_RF1AG064926_075 FIBRINOGEN AND VASCULAR COGNITIVE IMPAIRMENT: MECHANISMS, IMAGING, THERAPEUTICS - PROJECT SUMMARY / ABSTRACT TRADITIONALLY, NEUROLOGICAL DISEASES HAVE BEEN CLASSIFIED INTO MECHANI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2024 | $4,523,685 |
ASST_NON_W81XWH2110875_097 PHASE 1 CLINICAL TRIAL FOR THERAPEUTIC INTERVENTION PARTICLES TRANSFER AWARD FROM J. DAVID GLADSTONE INSTITUTES TO INSTITUTE FOR EVOLVABLE MEDICINES | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | OAKLAND, CA-12 | 2024 | $4,499,999 |
ASST_NON_R37NS101996_075 RARE VARIANT WHOLE GENOME ANALYSIS AND IPSC VALIDATION OF PUTATIVE GENETIC MODIFIERS OF HUNTINGTON DISEASE - PROJECT SUMMARY THE GOAL OF OUR STUDIES IS TO IDENTIFY AND VALIDATE GE… | Department of Health and Human Services National Institutes of Health | 93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS | CA-90 | 2024 | $4,405,638 |
ASST_NON_RF1AG059751_075 PROTEOMIC AND GENETIC APPROACHES DEFINING APOLIPOPROTEIN E4 NEUROPATHOLOGIC MECHANISMS - APOLIPOPROTEIN (APO) E4 IS THE MAJOR GENETIC RISK FACTOR FOR ALZHEIMER’S DISEASE (AD). IN… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2024 | $4,335,838 |
ASST_NON_R01AG071697_075 NEURONAL APOE DRIVES SELECTIVE NEURODEGENERATION IN ALZHEIMER'S DISEASE - PROJECT SUMMARY SELECTIVE NEURODEGENERATION IS A CRITICAL CAUSAL FACTOR IN ALZHEIMER’S DISEASE (AD); HOWE… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $4,070,240 |
ASST_NON_R01AI180651_075 TARGETING FEEDBACK CIRCUITRY FOR ANTIVIRAL THERAPY - PROJECT SUMMARY/ABSTRACT THE HUMAN HERPESVIRUS 5 (CYTOMEGALOVIRUS, CMV) INFECTS >50% OF THE WORLD’S POPULATION AND CAUSES SUBS… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | ROCKVILLE, MD-08 | 2024 | $3,965,737 |
ASST_NON_R01DK123746_075 MODELING INTESTINAL DYSFUNCTION IN HIV INFECTION WITH ORGANOID TECHNOLOGY - ABSTRACT DISRUPTION OF INTESTINAL EPITHELIAL BARRIER FUNCTION IS AN IMPORTANT CAUSE OF HIV-ASSOCIATED C… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | CA-90 | 2024 | $3,938,579 |
ASST_NON_U01HL157989_075 GENETIC DETERMINANTS OF 4D GENOME FOLDING IN HUMAN CARDIAC DEVELOPMENT - PROJECT SUMMARY A MAJOR UNANSWERED QUESTION IS HOW CHROMATIN TOPOLOGY COORDINATES HUMAN DEVELOPMENT AND CE… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | CA-90 | 2024 | $3,812,200 |
ASST_NON_R01AI147777_075 PHENOTYPIC AND MECHANISTIC ANALYSIS OF THE IN VIVO HIV LATENT RESERVOIR BY SINGLE-CELL TECHNOLOGIES - PROJECT SUMMARY COMBINATION ANTIRETROVIRAL THERAPY (ART) CAN SUPPRESS HIV RE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2024 | $3,800,124 |
ASST_NON_RF1AG062234_075 OPTOGENETIC DISSECTION OF CELLULAR AND CIRCUIT MECHANISMS OF NETWORK DYSFUNCTION AND AMYLOID DEPOSITION IN MOUSE MODELS OF ALZHEIMER'S DISEASE IN VIVO - SUMMARY A CONTRIBUTING FAC… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $3,753,379 |
ASST_NON_R01AG078164_075 DEVELOP AD CONNECTIVITY MAPS WITH HUMAN IPSC-DERIVED BRAIN CELLS AND THEIR USE - SUMMARY ALZHEIMER’S DISEASE (AD) IS A MULTIFACTORIAL NEURODEGENERATIVE DISORDER CAUSED BY INTERACT… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $3,748,222 |
ASST_NON_R01AG065428_075 DEFINING STRATEGIES TO TARGET ENERGY FAILURE IN METABOLICALLY VULNERABLE HUMAN CELLS - PROJECT SUMMARY DISRUPTED ENERGY METABOLISM IS A CENTRAL DRIVER OF DYSFUNCTION AND DEATH IN… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $3,708,781 |
ASST_NON_R01MH115679_075 THERAPEUTIC POTENTIAL AND MECHANISMS OF TAU REDUCTION IN AUTISM MODELS - PROJECT SUMMARY THE AUTISM SPECTRUM DISORDERS (ASDS) AFFECT 1% OF THE WORLD’S POPULATION. THE… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | SAN FRANCISCO, CA-11 | 2024 | $3,618,648 |
ASST_NON_R01AG064579_075 CELL AND NETWORK DISRUPTIONS AND ASSOCIATED PATHOGENENESIS IN TAUOPATHY AND DOWN SYNDROME - THE GOAL OF OUR STUDIES IS TO BETTER UNDERSTAND THE MECHANISMS BY WHICH TAU TRANSMISSIO… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $3,606,993 |
ASST_NON_R01AI189605_075 TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL REGULATION OF HUMAN TREG IDENTITY AND FUNCTION - ABSTRACT REGULATORY T CELLS (TREGS) ARE ESSENTIAL FOR MAINTAINING IMMUNE HOMEOSTASIS BY P… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN FRANCISCO, CA-11 | 2026 | $3,601,712 |
ASST_NON_RF1AG064170_075 UNDERSTAND AND PROBING DISRUPTED GLUCOSE METABOLISM IN ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) IS CHARACTERIZED BY EARLY AND PROMINENT CHANGES IN GLUCOSE ME… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2024 | $3,597,332 |
ASST_NON_R01AG065540_075 STUDY THE PROTECTIVE ROLES OF APOE2 IN ALZHEIMER'S DISEASE USING REPROGRAMMED ISOGENIC CELLS - THE COMPLEXITY AND MULTIFACTORIAL NATURE OF ALZHEIMER’S DISEASE (AD) POSE UNIQUE CHA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2024 | $3,596,860 |
ASST_NON_R01DA044605_075 ASSESSING THE ROOT CAUSES OF CHRONIC INFLAMMATION IN HIV-INFECTED INDIVIDUALS USING DRUGS OF ABUSE - PROJECT SUMMARY THIS STUDY SEEKS TO UNDERSTAND THE MOLECULAR EVENTS THAT TRIGG… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG ABUSE AND ADDICTION RESEARCH PROGRAMS | SAN FRANCISCO, CA-11 | 2024 | $3,572,745 |
ASST_NON_R01AG062629_075 DECIPHERING MOLECULAR PATHWAYS OF INHIBITORY INTERNEURON DYSFUNCTION IN ALZHEIMER'S DISEASE - SINCE RAMON Y CAJAL PROPOSED THAT THE BRAIN IS NOT A SINGLE RETICULAR UNIT BUT CONTAI… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $3,562,740 |
ASST_NON_R01AI191341_075 TRANSFORMING HIV VACCINE DESIGN WITH A HYBRID TECHNOLOGY THAT LEVERAGES FEATURES OF MRNA AND PROTEIN NANOPARTICLE PLATFORMS - PROPOSAL SUMMARY/ABSTRACT THE HIV-1/AIDS EPIDEMIC CON… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | CA-90 | 2025 | $3,559,750 |
ASST_NON_R01DA049525_075 EXPLORING HIV-ASSOCIATED NEUROCOGNITIVE DISORDER (HAND) AND HIV LATENCY AT THE SINGLE CELL LEVEL IN CEREBRAL ORGANOIDS - PROJECT SUMMARY FULLY HALF OF ALL HIV-INFECTED INDIVIDUALS… | Department of Health and Human Services National Institutes of Health | 93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS | CA-90 | 2026 | $3,540,000 |
ASST_NON_R01NS128909_075 ELUCIDATING MICROVASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT AT SINGLE-CELL RESOLUTION - PROJECT SUMMARY/ABSTRACT DEMENTIA AFFLICTS OVER 55 MILLION PEOPLE WORLDWIDE. WITH AN AG… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $3,305,290 |
ASST_NON_R01AG061150_075 APOLIPOPROTEIN E4-RELATED ELECTROPHYSIOLOGICAL AND METABOLIC IMPAIRMENTS IN AGING AND ALZHEIMER'S DISEASE - PROJECT SUMMARY THE COMPLEXITY AND MULTIFACTORIAL NATURE OF ALZHEIMER'S… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2025 | $3,278,370 |
ASST_NON_RF1AG060765_075 NOVEL THERAPEUTIC APPROACHES TO INCREASE PROGRANULIN LEVELS IN BRAIN TO TREAT FTD AND AD - PROGRANULIN (PGRN) IS A SECRETED, NEUROPROTECTIVE PROTEIN THAT HAS BEEN LINKED TO TWO OF… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $3,112,016 |
ASST_NON_HT94252410163_097 DEVELOPING A PRACTICAL FORM OF HYPOXIA THERAPY FOR MITOCHONDRIAL DISEASES SUCH AS 3-MGA. | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | SAN FRANCISCO, CA-90 | 2024 | $3,024,000 |
ASST_NON_R01DK131526_075 MULTIOMICS CHARACTERIZATION, INDUCTION, AND ELIMINATION OF THE HIV GUT RESERVOIR - PROJECT SUMMARY STUDIES IN ANIMAL MODELS HAVE SUGGESTED 98% OF THE HIV RESERVOIR TO RESIDE WITH… | Department of Health and Human Services National Institutes of Health | 93.847 DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $2,937,487 |
ASST_NON_R01CA276368_075 DECODING AND REPROGRAMMING T CELLS THROUGH SYNTHETIC BIOLOGY FOR CANCER IMMUNOTHERAPY - ABSTRACT ENGINEERED T CELL-BASED CANCER THERAPIES ARE A MAJOR ADVANCEMENT IN CANCER TREATME… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $2,906,741 |
ASST_NON_DP2GM140917_075 ENGINEERED MITOCHONDRIA FOR THERAPEUTIC DONATION AND MITOCHONDRIAL GENOME EDITING - PROJECT SUMMARY/ABSTRACT THE ~SIXTEEN-THOUSAND NUCLEOTIDES OF THE MITOCHONDRIAL GENOME PLAY AN… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | CA-90 | 2025 | $2,835,000 |
ASST_NON_R01AG085468_075 STUDY ALZHEIMER'S DISEASE PROTECTIVE APOE VARIANTS - PROJECT SUMMARY THE COMPLEXITY AND MULTIFACTORIAL NATURE OF ALZHEIMER’S DISEASE (AD) POSE UNIQUE CHALLENGES FOR MECHANISTIC ST… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $2,805,264 |
ASST_NON_R01HL160862_075 LINKING MICROBIOME GENETIC VARIANTS WITH CARDIOVASCULAR PHENOTYPES IN 50,000 INDIVIDUALS - PROJECT SUMMARY / ABSTRACT THE HUMAN BODY IS HOME TO A COMPLEX COMMUNITY OF MICROORGANIS… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $2,748,578 |
ASST_NON_R01HL150100_075 AORTIC VALVE DISEASE: MECHANISMS AND THERAPEUTIC APPROACHES - AORTIC VALVE STENOSIS IS THE MAJOR CAUSE OF VALVE DISEASE IN THE WESTERN WORLD, AND THE THIRD LEADING CAUSE OF ADULT… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2025 | $2,716,496 |
ASST_NON_R01AI183286_075 TARGETING THE TRANSCRIPTIONALLY-ACTIVE RESERVOIR TO REDUCE CHRONIC INFLAMMATION IN AGED PEOPLE WITH HIV - PROJECT SUMMARY RECENT DATA SUGGEST THAT A SUBSTANTIAL FRACTION OF THE H… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | SAN FRANCISCO, CA-11 | 2024 | $2,697,266 |
ASST_NON_RF1AG076647_075 STUDY SUSCEPTIBILITY AND RESISTANCE TO APOE4 IN ALZHEIMER'S DISEASE - SUMMARY THE COMPLEXITY AND MULTIFACTORIAL NATURE OF ALZHEIMER’S DISEASE (AD) POSE UNIQUE CHALLENGES FOR MECHA… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2026 | $2,637,009 |
ASST_NON_DP2HG012442_075 SINGLE-CELL CHEMICAL TRANSCRIPTOMIC DISSECTION OF AN ESSENTIAL TRANSCRIPTION FACTOR NETWORK - PROJECT SUMMARY / ABSTRACT BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | CA-90 | 2024 | $2,587,500 |
ASST_NON_R01MH123178_075 RESOLVING SINGLE-CELL BRAIN REGULATORY ELEMENTS WITH BULK DATA SUPERVISED MODELS - GENE REGULATION IS AN IMPORTANT DETERMINANT OF THE COMPLEX SPECIALIZATION OF CELLS IN THE HUMAN… | Department of Health and Human Services National Institutes of Health | 93.242 MENTAL HEALTH RESEARCH GRANTS | SAN FRANCISCO, CA-11 | 2025 | $2,426,300 |
ASST_NON_R01HL155906_075 GENE REGULATORY NETWORKS FOR HEART DEVELOPMENT - PROJECT SUMMARY CONGENITAL HEART DEFECTS (CHDS) ARE THE MOST PREVALENT AND SERIOUS BIRTH DEFECTS, OCCURRING IN OVER 1% OF LIVE BIR… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | CA-90 | 2024 | $2,410,652 |
ASST_NON_RF1NS124848_075 DISSECTING THE ETIOLOGY OF THE LEWY BODY DEMENTIAS - PROJECT SUMMARY LEWY BODY DEMENTIA (LBD) IS THE SECOND MOST COMMON NEURODEGENERATIVE DISORDER, AFFLICTING 1 MILLION PEOPLE IN… | Department of Health and Human Services National Institutes of Health | 93.866 AGING RESEARCH | CA-90 | 2026 | $2,383,188 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.866 — AGING RESEARCH$106.9M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$70.5M
93.837 — CARDIOVASCULAR DISEASES RESEARCH$45.6M
93.279 — DRUG USE AND ADDICTION RESEARCH PROGRAMS$21.2M
93.853 — EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS$21.1M
93.310 — TRANS-NIH RESEARCH SUPPORT$15.9M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$9.0M
93.847 — DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH$6.9M
93.242 — MENTAL HEALTH RESEARCH GRANTS$6.0M
93.396 — CANCER BIOLOGY RESEARCH$4.4M
Source: USAspending.gov · All Recipients · Maryland